DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Prorenoate potassium
Prorenoate potassium
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
(12) Patent Application Publication (10) Pub. No.: US 2006/0024365A1 Vaya Et Al
General Agreement on Tariffs Andtrade
The Organic Chemistry of Drug Synthesis
Network-Based Characterization of Drug-Protein Interaction Signatures
(12) Patent Application Publication (10) Pub. No.: US 2002/0102215 A1 100 Ol
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
G.P. Ellis (3).Pdf
Stembook 2018.Pdf
X-Ray Microscope Röntgenstrahlmikroskop Microscope À Rayons X
WO 2016/066256 Al 6 May 2016 (06.05.2016) W P O P C T
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Pharmaabkommen A1 E
TAR/W/87 21 Juin 1993 DOUANIERS ET LE COMMERCE Distribution Limitée
Wo 2007/044693 A2
(12) Patent Application Publication (10) Pub. No.: US 2005/0002865 A1 Klaveness Et Al
WO 2015/070019 Al 14 May 2015 (14.05.2015) P O P C T
Top View
Spironolactone, but Not Eplerenone, Impairs Glucose Tolerance in a Rat Model of Metabolic Syndrome
Harmonized Tariff Schedule of the United States (2006) (Rev
General Agreement on Tariffs Andtrade
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
(12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
(12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428
1111111111111111111Imnumu
List of Apis (1758)
(12) Patent Application Publication (10) Pub. No.: US 2016/0271174 A1 KEYSER Et Al
(12) Patent Application Publication (10) Pub. No.: US 2014/0052264 A1 Hufen Et Al
WO 2007/016766 Al
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428